REQUEST A DEMO
Total
USD $0.00
Search more companies

Na15 Pharma Integrate Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: Na15 Pharma Integrate Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Na15 Pharma Integrate Company Limited is an enterprise located in Thailand, with the main office in Bangkok , Special Governed District of. It operates in the Pharmacies and Drug Stores industry. It was established on May 20, 2026. It currently has a total number of 5 (2024) employees. There was a net sales revenue increase of 14.99% reported in Na15 Pharma Integrate Company Limited’s latest financial highlights for 2024. There was a total growth of 3.03% in Na15 Pharma Integrate Company Limited’s total assets over the same period. Na15 Pharma Integrate Company Limited’s net profit margin increased by 5.73% in 2024.

Headquarters
507 Lasalle Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10260

Contact Details: Purchase the Na15 Pharma Integrate Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Na15 Pharma Integrate Company Limited report to view the information.
Financial Auditors:
Purchase the Na15 Pharma Integrate Company Limited report to view the information.
Incorporation Date:
May 20, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Na15 Pharma Integrate Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
14.99%
Total Operating Revenue
15.02%
Operating Profit
10.38%
EBITDA
10.38%
Net Profit/Loss for the Period
10.4%
Total Assets
3.03%
Total Equity
-46.91%
Operating Profit Margin
5.73%
Net Profit Margin
5.73%
Return on Equity (ROE)
-20.43%
Debt / Equity
14.37%
Quick Ratio
-0.02%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?